Loading...
NPI 1659722114 · Wasilla, AK · Methadone Clinic
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Community Medical Services Montana Private LLC is a methadone clinic provider located in Wasilla, Alaska. This profile covers 2 Medicare and 23 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Community Medical Services Montana Private LLC |
| Address | 2521 E. Mountain Village Drive Suites E And F |
| City | Wasilla |
| State | AK |
| ZIP | 99654 |
| Taxonomy | Methadone Clinic |
| NPI Enumerated | June 27, 2016 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $18.9M |
| Medicare | $395.9K |
COMMUNITY MEDICAL SERVICES MONTANA PRIVATE LLC is operating as a methadone clinic and opioid treatment program based on its taxonomy and dominant procedure mix: Medicare billing is almost entirely G2067/G2077 (medication-assisted treatment and periodic assessment), while Medicaid billing is dominated by H0033/H0020 (direct-observed oral medication administration and methadone administration) alongside substantial E/M and toxicology volumes. The presence of weekly bundled OTP codes on Medicare and high-volume observed medication codes on Medicaid indicates the business model centers on office-based methadone dispensing with integrated counseling, group therapy, and urine drug testing.
Medicare revenue is narrowly concentrated: the top three Medicare codes account for 100.0% of the provider’s Medicare revenue, with G2067 alone representing $368.5K (93.2% of Medicare revenue). G2067 ranks #183 of 830 nationally (78th percentile) and is described as a typical, unremarkable volume for this code, while the complementary assessment code G2077 accounts for the remainder ($26.8K, 6.8%) and ranks high among peers (#24 of 352, 93rd percentile).
Medicaid revenue is also concentrated in a small set of treatment codes: the top three Medicaid codes account for 89.7% of Medicaid revenue, led by H0033 at $12.3M (65.3%), H0020 at $3M (16.1%), and 99214 at $1.6M (8.3%). This concentration shows the provider’s Medicaid business is driven primarily by observed medication administration and routine methadone services, supplemented by higher-complexity office visits billed under 99214.
The payer mix strongly favors Medicaid: total Medicaid revenue is $18.9M versus total Medicare revenue of $395.9K, so the provider functions overwhelmingly as a Medicaid-funded OTP in scale. While Medicare billing exists and mirrors the OTP service line, Medicaid is the dominant source of revenue and volume for its core dispensing and testing services.
Within the state competitive landscape the provider is a major player for medication administration and related services: H0033 ranks #2 of 20 in-state (95th percentile) and is characterized as notably above typical state volume, while H0020 ranks #3 of 8 in-state (71st percentile) at a typical state volume. Additionally, 99214 ranks #16 of 440 in-state (97th percentile) and is flagged as notably above typical state volume, which suggests the provider captures a large share of higher-complexity E/M visits for this service in its market.
Laboratory and toxicology testing volumes are an important and unusual feature of the Medicaid profile: 80307 is an extreme outlier in-state (rank #1 of 23, 100th percentile) with $1.2M in revenue (6.3% of Medicaid revenue), indicating exceptionally high use of instrumented presumptive drug testing compared with peers. This pattern points to substantial on-site or contracted testing capacity that supports frequent monitoring in an OTP setting.
On national Medicare footing the provider shows a modest to mid-tier presence for OTP billing: G2067’s position at the 78th percentile (rank #183 of 830) is described as typical/unremarkable volume nationally, so the provider is not a dominant national Medicare operator for this code despite local scale on Medicaid. By contrast, the G2077 assessment code performs strongly versus Medicare peers (rank #24 of 352, 93rd percentile), implying above-average billing frequency for periodic assessments among Medicare-enrolled OTPs.
The provider has an established billing history with NPI enumeration on 2016-06-27 (~10 years ago), supporting roughly a decade of operations and claims activity. Combined with the concentrated revenue mix and high in-state ranks on core dispensing and testing codes, the tenure and coding profile are consistent with a stable, specialized methadone treatment operation focused on Medicaid populations.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 1,250 | $300 | $368.5K |
| G2077 | Periodic assessment; assessing periodically by an otp practitioner and includes a review of moud dosing, treatment response, other substance use disorder treatment needs, responses and… | 190 | $150 | $26.8K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 2 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
23 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| H0033 | Oral medication administration, direct observation | 224,040 | $60 | $12.3M |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 89,150 | $30 | $3M |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 15,220 | $100 | $1.6M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 37,230 | $30 | $1.2M |
| T1016 | Case management, each 15 minutes | 7,890 | $30 | $220.8K |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | 560 | $370 | $204.4K |
| H0001 | Alcohol and/or drug assessment | 720 | $190 | $133.9K |
| H2015 | Comprehensive community support services, per 15 minutes | 4,580 | $30 | $123.6K |
| H0046 | Mental health services, not otherwise specified | 660 | $40 | $24.9K |
| 90832 | In this service, the provider performs psychotherapy, a series of techniques for treating the psychiatric disorders of the patient. The treatment session with the patient typically lasts for anywhere… | 280 | $50 | $13.6K |
Showing 1–10 of 23
How this provider's Medicaid billing volume and revenue compare to other Alaska providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Alaska median
23 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 3 | 10 | 36,340 | $80 | $10.5M |
| H2017 | Psychosocial rehabilitation services, per 15 minutes | 10 | 10 | 2,750 | $280 | $3.3M |
| H2019 | Therapeutic behavioral services, per 15 minutes | 27 | 40 | 3,660 | $250 | $3.1M |
| H0033 | Oral medication administration, direct observation | 2 | 20 | 3,510 | $60 | $2.1M |
| H2015 | Comprehensive community support services, per 15 minutes | 32 | 60 | 4,510 | $230 | $1.8M |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 401 | 490 | 680 | $260 | $1M |
| T1016 | Case management, each 15 minutes | 14 | 90 | 1,620 | $150 | $606.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 16 | 440 | 580 | $170 | $458.7K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 1 | 20 | 1,530 | $60 | $326K |
| 86580 | The lab analyst performs an intradermal skin test on a patient to test for tuberculosis. | 7 | 20 | 130 | $430 | $277.4K |
Showing 1–10 of 23
Other providers in the same ZIP code as Community Medical Services Montana Private LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.